Sublicense for Humanitarian Purposes Granted to Global Vaccines
FT. LAUDERDALE, Fla. and CHAPEL HILL, N.C., Jan. 28 /PRNewswire-FirstCall/ -- InkSure Technologies Inc. (OTC Bulletin Board: INKS), a leading provider of covert machine-readable security solutions ("CMRT") for the detection of counterfeiting, fraud and diversion, and AuthentiForm Technologies, L.L.C., a developer of innovative authentication and item-level identification technologies, today announced that they have entered into an assignment agreement by which InkSure has acquired AuthentiForm's entire intellectual property portfolio of enhanced product-authentication technology.
The AuthentiForm portfolio includes methods to establish authenticity and identify products at the item level by encoding high information-density, invisible, and essentially tamper-proof signatures within a product's formulation, on its surface, or through incorporation into its packaging. AuthentiForm technology enables dynamic codes without substantially changing the chemical composition of a product or its components, which makes the AuthentiForm technology particularly attractive for use with pharmaceutical products.
"We have been impressed with AuthentiForm's developments for some time and believe that its enhanced product identification techniques will be very compatible with a new InkSure product line in development," commented Yaron Meerfeld, Chief Operating Officer of InkSure Technologies Inc. "Brand owners want more than authentication products: they are looking for solutions," added Mr. Meerfeld. "We believe that this addition to our authentication and track-and-trace capabilities will offer new and exciting solutions to our portfolio."
"InkSure emerged as the assignee of choice because of its forward-thinking stance on the technology's value," stated AuthentiForm's Managing Owner Tom Mercolino.
As a further condition of the assignment agreement, InkSure has granted back to AuthentiForm the right to license its portfolio for humanitarian uses. AuthentiForm will sublicense some of the technology's humanitarian-use rights to Global Vaccines, Inc. (GVI), a non-profit vaccine company. "InkSure has shown its commitment to reducing the insidious effects of counterfeit products by agreeing that AuthentiForm may retain humanitarian-use rights," Mercolino said. "I am delighted that Global Vaccines will be able to use AuthentiForm to protect its vaccines for people in the developing world."
"The AuthentiForm technology will help Global fulfill its mission of delivering safe and effective vaccines to the developing world," said GVI's Director of Development Jake Wiltshire. "Because it will ensure that people in developing countries are not receiving counterfeit products, it's a wonderful addition to our existing vaccine portfolio."
About InkSure Technologies Inc.
InkSure Technologies Inc., with its corporate headquarters in Ft. Lauderdale, Florida and its research and development center in Science Park, Rehovot, Israel, specializes in comprehensive, covert security solutions designed to protect high profile brands and documents of value from counterfeiting, fraud and diversion. The Company's sales and marketing activities target a number of market opportunities, including financial, pharmaceutical, branded products, transportation, and government/institutional, on a global scale. The Company's R&D activities include the development of "chipless" RFID technology for affordable item-level secure logistics and track-and-trace applications.
The Company's common stock is listed on the OTC Bulletin Board under the symbol "INKS". Additional information on the Company is available on its website at http://www.inksure.com.
About AuthentiForm Technologies, L.L.C.
AuthentiForm Technologies, L.L.C. is a privately held company with an office in Chapel Hill, North Carolina. AuthentiForm's business focuses on developing methods to unequivocally establish product authenticity.
Statements contained in this Press Release, other than statements of
historical facts, are forward-looking statements subject to a number of
uncertainties that could cause actual events or results to differ
materially from some statements made.
For further information, please contact:
James Assaf, General Manager, InkSure Inc. +1-954-772-8507 or via e-mail
Thomas J. Mercolino, Managing Owner, AuthentiForm Technologies, L.L.C.,
908-963-9387 or via email at email@example.com.
|SOURCE InkSure Technologies Inc.|
Copyright©2008 PR Newswire.
All rights reserved